Table 2 treatment’s characteristic
From: Superior sulcus non small cell lung carcinoma: retrospective analysis of 42 patients
Treatment | # Patients | % Patients |
|---|---|---|
Chemotherapy | 36 | 85.7 |
# Mean cycle (min-max) | 4 (2–6) | |
Cisplatinum-vinorelbine | 23 | 54.8 |
Carboplatin paclitaxel | 10 | 23.8 |
Unknown | 3 | 7.1% |
Radiotherapy: total dose/dose per fraction | ||
66 Gy/2 Gy | 8 | 19 |
46 Gy/2 Gy | 22 | 52.4 |
Miscellaneous | 12 | 28.6 |
Surgery | 22 | 50% |
En bloc resection | 2 | 9.5 |
En bloc resection + lymph node dissection | 20 | 90.5 |
Treatment | ||
Exclusive radiation treatment | 3 | 7.1 |
Exclusive chemoradiotherapy | 17 | 40.5 |
Radiation treatment + surgery | 19 | 45.3 |
Chemoradiotherapy + surgery | 3 | 7.1 |